Chipscreen Biosciences, Ltd.

Works in Dermatology · GI & liver · Hematology · Immunology · Metabolic & endocrine · Oncology · Renal & urogenital · Respiratory · Women's health

Chipscreen Biosciences, Ltd. is a clinical trial sponsor. It has 11 active clinical trials with 6,118 planned participants, across 9 therapeutic areas. Since 2021 it has completed 22 trials and stopped 1 early.

Trial track record · since 2021

11Active trials6,118 planned participants
22Completed0 with results posted
1Stopped early4% of finished trials

Pipeline · 11 active trials

StageTrialStatus

Questions about Chipscreen Biosciences, Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-05.

Approve Suite is not affiliated with Chipscreen Biosciences, Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.